tm logo

Monitor this mark

View On USPTO

CIRIUS THERAPEUTICS
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 28 Oct 2024

Last Applicant/ Owned by

CIRIUS THERAPEUTICS, INC.

171 MONROE AVE NW

GRAND RAPIDS

MI

49503

Serial Number

87382718 filed on 23rd Mar 2017

Registration Number

5465927 registered on 08th May 2018

in the Principal Register

Correspondent Address

Mary C. Bonnema

Mary C. Bonnema Warner Norcross + Judd LLP

Suite 1500

Grand Rapids, MI 49503

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

CIRIUS THERAPEUTICS

Research and development of pharmaceuticals and therapeutic products for treatment of liver disease

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Research and development of pharmaceuticals and therapeutic products for treatment of liver disease

First Use Date in General

11th Apr 2017

First Use Date in Commerce

11th Apr 2017

Mark Details

Serial Number

No 87382718

Mark Type

No Service Mark

Attorney Docket Number

No 178500210251

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
28th Oct 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
28th Oct 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
28th Oct 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06th May 2024TEAS SECTION 8 & 15 RECEIVED
19th Jul 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
19th Jul 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19th Jul 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19th Jul 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19th Jul 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
08th May 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED